Literature DB >> 20416462

Post-tonsillectomy bleeding in children with von Willebrand disease: a single-institution experience.

Kenneth D Rodriguez1, Gordon H Sun, Francis Pike, Ellen M Mandel, Margaretha L Casselbrant, David H Chi.   

Abstract

OBJECTIVES: 1) Compare rates of post-tonsillectomy bleeding in pediatric patients with and without von Willebrand disease (vWD). 2) Identify factors that may increase the risk for post-tonsillectomy bleeding in children with and without vWD. STUDY
DESIGN: Historical cohort study.
SETTING: Tertiary care, university-based pediatric hospital. SUBJECTS AND METHODS: Medical records were examined for 99 patients with vWD and 99 patients without vWD younger than 18 years who underwent tonsillectomy with or without adenoidectomy from August 1997 to October 2005. Subjects were matched for age, year of surgery, type of surgery, and indication for surgery.
RESULTS: Post-tonsillectomy hemorrhage occurred in eight of 99 (8%) vWD patients and in six of 99 (6%) non-vWD patients (P = 0.58, odds ratio 1.36, 95% CI 0.45-4.08). A two-sample test of proportions demonstrated lower and upper limits of -0.051 and 0.092. Four of eight children with vWD and two of six non-vWD patients required surgical intervention for control of bleeding. Ninety-three of 99 vWD patients received desmopressin acetate (DDAVP) preoperatively. In patients with vWD who responded to DDAVP challenge, there was no increased likelihood of post-tonsillectomy bleeding compared with non-vWD patients. No significant difference in the number of bleeding events was noted on the basis of demographics, preoperative laboratories, or use of aminocaproic acid.
CONCLUSION: Children with vWD undergoing tonsillectomy have a postoperative bleeding rate similar to that of a matched group. However, the sample size was not sufficient to eliminate the possibility of a clinically important difference between the two groups. Copyright 2010 American Academy of Otolaryngology-Head and Neck Surgery Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20416462      PMCID: PMC3275349          DOI: 10.1016/j.otohns.2010.01.029

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  22 in total

Review 1.  Treatment of von Willebrand's Disease.

Authors:  Pier Mannuccio Mannucci
Journal:  N Engl J Med       Date:  2004-08-12       Impact factor: 91.245

2.  Preoperative coagulation screening for adenotonsillectomy: a review and comparison of current physician practices.

Authors:  Aaron Wieland; Laura Belden; Michael Cunningham
Journal:  Otolaryngol Head Neck Surg       Date:  2009-04       Impact factor: 3.497

3.  von Willebrand factor is an acute phase reactant in man.

Authors:  B E Pottinger; R C Read; E M Paleolog; P G Higgins; J D Pearson
Journal:  Thromb Res       Date:  1989-02-15       Impact factor: 3.944

4.  High levels of plasma von Willebrand factor in hyperthyroidism.

Authors:  M Cuianu; A Nussbaum; A Cristea; T Vlăduţiu; S Roman; D Stoica
Journal:  Med Interne       Date:  1987 Jul-Sep

5.  Structure of the gene for human von Willebrand factor.

Authors:  D J Mancuso; E A Tuley; L A Westfield; N K Worrall; B B Shelton-Inloes; J M Sorace; Y G Alevy; J E Sadler
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

6.  Causes of tonsillar disease and frequency of tonsillectomy operations.

Authors:  P S Mattila; O Tahkokallio; J Tarkkanen; J Pitkäniemi; M Karvonen; J Tuomilehto
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-01

Review 7.  Diagnosis and treatment of von Willebrand disease.

Authors:  Joan Cox Gill
Journal:  Hematol Oncol Clin North Am       Date:  2004-12       Impact factor: 3.722

8.  Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children.

Authors:  Jack L Paradise; Charles D Bluestone; D Kathleen Colborn; Beverly S Bernard; Howard E Rockette; Marcia Kurs-Lasky
Journal:  Pediatrics       Date:  2002-07       Impact factor: 7.124

9.  Factor VIII activity and thyroid function.

Authors:  J S Rogers; S R Shane; F S Jencks
Journal:  Ann Intern Med       Date:  1982-11       Impact factor: 25.391

10.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

View more
  2 in total

1.  [Bleeding and coagulation disorders in tonsillectomies].

Authors:  K Papaspyrou; H von Creytz; K Kolonko; T Mewes; W Mann; I Scharrer
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

2.  The utility of the DDAVP challenge test in children with low von Willebrand factor.

Authors:  Natasha M Archer; Mihail Samnaliev; Rachael Grace; Carlo Brugnara
Journal:  Br J Haematol       Date:  2015-03-02       Impact factor: 6.998

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.